Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
13.84
-0.55 (-3.82%)
At close: Mar 6, 2026, 4:00 PM EST
13.81
-0.03 (-0.22%)
After-hours: Mar 6, 2026, 7:17 PM EST
Oscar Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Oscar Health stock have an average target of 17, with a low estimate of 11 and a high estimate of 25. The average target predicts an increase of 22.83% from the current stock price of 13.84.
Analyst Consensus: Hold
* Price targets were last updated on Jan 9, 2026.
Analyst Ratings
The average analyst rating for Oscar Health stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 2 | 3 | 5 | 5 | 5 |
| Sell | 4 | 3 | 2 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Sell → Hold Upgrades $12 → $17 | Strong Sell → Hold | Upgrades | $12 → $17 | +22.83% | Jan 9, 2026 |
| Barclays | Barclays | Sell → Hold Upgrades $13 → $18 | Sell → Hold | Upgrades | $13 → $18 | +30.06% | Jan 5, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $17 | Hold | Initiates | $17 | +22.83% | Dec 11, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $13 → $25 | Hold → Buy | Upgrades | $13 → $25 | +80.64% | Nov 26, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $14 → $11 | Sell | Maintains | $14 → $11 | -20.52% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
19.16B
from 11.70B
Increased by 63.73%
Revenue Next Year
20.19B
from 19.16B
Increased by 5.40%
EPS This Year
0.57
from -1.69
EPS Next Year
1.31
from 0.57
Increased by 128.97%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.9B | 23.4B | |
| Avg | 19.2B | 20.2B | |
| Low | 17.9B | 15.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.3% | 21.9% | |
| Avg | 63.7% | 5.4% | |
| Low | 53.1% | -20.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.21 | 1.86 | |
| Avg | 0.57 | 1.31 | |
| Low | -0.62 | -0.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 225.4% | |
| Avg | - | 129.0% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.